Douglas Smith is a Psychiatry physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
350 Pee Dee Ave
Suite A
Albemarle, NC 280014932
Telephone
704-983-8868Registry record last updated 4 Feb 2014.
Clinical trials
3 registered studies on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20256 payments
- Neurocrine BioSciences, Inc.Program year20251 payment
- Janssen Pharmaceuticals, IncProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
92.1%Atypical Antipsychotic36.4%Invega Sustenna25%Quetiapine Fumarate22%Aripiprazole13%Abilify Maintena12%Olanzapine7%Lurasidone Hcl4%Risperidone4%Quetiapine Fumarate Er3%Vraylar3%Invega Trinza3%Clozapine2%Uzedy2%Part D<11 patientsSSRI10.5%Trazodone Hcl67%Escitalopram Oxalate13%Paroxetine Hcl12%Sertraline Hcl7%Part D<11 patients+ 16 more classes in this area
Metabolism & gastrointestinal
3.7%Biguanide (metformin)1.4%Metformin Hcl100%Part D<11 patientsSulfonylurea0.9%Glipizide Er100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
3%alpha-Adrenergic Blocker2%Prazosin Hcl100%Part D<11 patientsBeta blocker1%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”